Beijing based medical technology company HYGEA Medraised nearly ¥200 million in a series B round funding led by Jianxing Medical Fund managed by CCB International andfoolowd by Kun Ying capital and Shunxi Fund. The investment will be used to improve market coverage and channel building, accelerate product R&D, and launch internation stratgy.
HYGEA foucuses on using medical engineering technology and manufacturing techniques of smart apparatus to devleop and produce minimal invasive cryotherapy system for complex tumors and provide solutions to minimal invasive interventional therapy for series tumors.
South Africa Today